Xu, J.; Dai, Y.; Gao, Y.; Chai, R.; Lu, C.; Yu, B.; Kang, Y.; Xu, C.
RAD51D Secondary Mutation-Mediated Resistance to PARP-Inhibitor-Based Therapy in HGSOC. Int. J. Mol. Sci. 2023, 24, 14476.
https://doi.org/10.3390/ijms241914476
AMA Style
Xu J, Dai Y, Gao Y, Chai R, Lu C, Yu B, Kang Y, Xu C.
RAD51D Secondary Mutation-Mediated Resistance to PARP-Inhibitor-Based Therapy in HGSOC. International Journal of Molecular Sciences. 2023; 24(19):14476.
https://doi.org/10.3390/ijms241914476
Chicago/Turabian Style
Xu, Jing, Yilin Dai, Yi Gao, Ranran Chai, Chong Lu, Bing Yu, Yu Kang, and Congjian Xu.
2023. "RAD51D Secondary Mutation-Mediated Resistance to PARP-Inhibitor-Based Therapy in HGSOC" International Journal of Molecular Sciences 24, no. 19: 14476.
https://doi.org/10.3390/ijms241914476
APA Style
Xu, J., Dai, Y., Gao, Y., Chai, R., Lu, C., Yu, B., Kang, Y., & Xu, C.
(2023). RAD51D Secondary Mutation-Mediated Resistance to PARP-Inhibitor-Based Therapy in HGSOC. International Journal of Molecular Sciences, 24(19), 14476.
https://doi.org/10.3390/ijms241914476